Cargando…
Pharmacological intervention to restore connectivity deficits of neuronal networks derived from ASD patient iPSC with a TSC2 mutation
BACKGROUND: Tuberous sclerosis complex (TSC) is a rare genetic multisystemic disorder resulting from autosomal dominant mutations in the TSC1 or TSC2 genes. It is characterised by hyperactivation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway and has severe neurodevelopmental and...
Autores principales: | Alsaqati, Mouhamed, Heine, Vivi M., Harwood, Adrian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574213/ https://www.ncbi.nlm.nih.gov/pubmed/33076974 http://dx.doi.org/10.1186/s13229-020-00391-w |
Ejemplares similares
-
Neuron-Glia Interactions Increase Neuronal Phenotypes in Tuberous Sclerosis Complex Patient iPSC-Derived Models
por: G. Nadadhur, Aishwarya, et al.
Publicado: (2018) -
Copy number variants (CNVs): a powerful tool for iPSC-based modelling of ASD
por: Drakulic, Danijela, et al.
Publicado: (2020) -
Quantitative proteomic analysis of Rett iPSC-derived neuronal progenitors
por: Varderidou-Minasian, Suzy, et al.
Publicado: (2020) -
NRXN1α(+/-) is associated with increased excitability in ASD iPSC-derived neurons
por: Avazzadeh, Sahar, et al.
Publicado: (2021) -
Differential Maturation of the Two Regulated Secretory Pathways in Human iPSC-Derived Neurons
por: Emperador Melero, Javier, et al.
Publicado: (2017)